J&J Manufacturing Woes Lead To Recall Of Children's Tylenol In Korea
This article was originally published in PharmAsia News
Executive Summary
Johnson & Johnson's Janssen subsidiary ordered a recall of all 1.7 million bottles of its Children's Tylenol syrup produced and sold in South Korea, citing excessive levels of acetaminophen, which could cause liver damage.
Johnson & Johnson's Janssen Korea subsidiary ordered a recall of all 1.7 million bottles of its Children's Tylenol syrup produced and sold in South Korea, citing excessive levels of acetaminophen, which could cause liver damage. A J&J spokeswoman said the levels of the API were "slightly out of specification" in some bottles and health risks were remote and apologized to South Koreans for causing a concern. South Korea's Ministry of Food and Drug Safety is conducting an investigation into possible regulatory and guideline production violations. The incident is the latest in a series of J&J production problems over the past four years. (Click here for more - a subscription may be required
)
"J&J Recalls All Bottles Of Children's Tylenol In South Korea" - Wall Street Journal (5/3/2013)